Nonalcoholic Steatohepatitis (NASH) Summit Europe 2017
In-Person Event
Oct 10 - 12, 2017
Frankfurt am Main, Hessen, DE
OVERVIEW
Nonalcoholic Steatohepatitis (NASH) Summit Europe is organized by Hanson Wade and would be held during Oct 10 - 12, 2017 at The Westin Grand Frankfurt, Frankfurt am Main, Hessen, Germany.
Focussed exclusively on NASH and built with industry experts at Novo Nordisk, Phenex and Gubra this summit will give you the latest insight and connections to solve the challenges you face from discovery to late stage clinical development.
Across 3 packed days eighty of the field greatest minds will converge at this unique summit to discover and validate novel NASH targets to improve drug efficacy, better recapitulate human NASH preclinically, effectively translate into the clinic and robustly diagnose patient pathology.
Conference Objectives :
• Effectively translate into the clinic by harnessing preclinical models which better recapitulate human NASH
• Evaluate the most progressive opportunities in noninvasive diagnostics to determine disease diagnosis and regression
• Define clinical primary and secondary endpoints and successfully bring a NASH drug to market
• Improve understanding of core disease pathways to identify and validate novel NASH targets
• Discover how NASH impacts other body organs to develop more efficacious drugs
Price :
Gold - conference and 2 workshops: EUR 3497
Silver - conference and 1 workshop : EUR 2998
Bronze - conference only: EUR 2499
Speakers :
Pierre Broqua, Pnina Fishman, Claus Kremoser, Dean Hum, Gerd Kullak-Ublick, Hans Schambye, James Trevaskis, Liat Hayardeny, Marie Wickström Lindholm, Matthias Ocker, Peter Traber, Philippe Weisel, Ronit Shiri-Sverdlov, Sophie Mégnien, Thomas Landh, Weilin Xie, George O’Rourke, Alice Chen
Additional details will be posted as soon as they are available.
Focussed exclusively on NASH and built with industry experts at Novo Nordisk, Phenex and Gubra this summit will give you the latest insight and connections to solve the challenges you face from discovery to late stage clinical development.
Across 3 packed days eighty of the field greatest minds will converge at this unique summit to discover and validate novel NASH targets to improve drug efficacy, better recapitulate human NASH preclinically, effectively translate into the clinic and robustly diagnose patient pathology.
Conference Objectives :
• Effectively translate into the clinic by harnessing preclinical models which better recapitulate human NASH
• Evaluate the most progressive opportunities in noninvasive diagnostics to determine disease diagnosis and regression
• Define clinical primary and secondary endpoints and successfully bring a NASH drug to market
• Improve understanding of core disease pathways to identify and validate novel NASH targets
• Discover how NASH impacts other body organs to develop more efficacious drugs
Price :
Gold - conference and 2 workshops: EUR 3497
Silver - conference and 1 workshop : EUR 2998
Bronze - conference only: EUR 2499
Speakers :
Pierre Broqua, Pnina Fishman, Claus Kremoser, Dean Hum, Gerd Kullak-Ublick, Hans Schambye, James Trevaskis, Liat Hayardeny, Marie Wickström Lindholm, Matthias Ocker, Peter Traber, Philippe Weisel, Ronit Shiri-Sverdlov, Sophie Mégnien, Thomas Landh, Weilin Xie, George O’Rourke, Alice Chen
Additional details will be posted as soon as they are available.
KEY DATES
10 Oct, 2017
Event Start Date
12 Oct, 2017
Event End Date
SPECIALITIES
GastroenterologySUGGESTED HOTELS
CONFERENCE VENUE
The Westin Grand FrankfurtRELATED CONFERENCES & LIVE WEBINARS
Quick Links